IL196824A0 - Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy - Google Patents

Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy

Info

Publication number
IL196824A0
IL196824A0 IL196824A IL19682409A IL196824A0 IL 196824 A0 IL196824 A0 IL 196824A0 IL 196824 A IL196824 A IL 196824A IL 19682409 A IL19682409 A IL 19682409A IL 196824 A0 IL196824 A0 IL 196824A0
Authority
IL
Israel
Prior art keywords
chemotherapy
contributing
treatment
methods
pharmaceutical preparations
Prior art date
Application number
IL196824A
Original Assignee
Luigi Lenaz
Guru Reddy
Dorla Mirejovsky
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luigi Lenaz, Guru Reddy, Dorla Mirejovsky, Spectrum Pharmaceuticals Inc filed Critical Luigi Lenaz
Publication of IL196824A0 publication Critical patent/IL196824A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL196824A 2006-08-01 2009-02-01 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy IL196824A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82108206P 2006-08-01 2006-08-01
PCT/US2007/075008 WO2008017000A2 (en) 2006-08-01 2007-08-01 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy

Publications (1)

Publication Number Publication Date
IL196824A0 true IL196824A0 (en) 2009-11-18

Family

ID=38744846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196824A IL196824A0 (en) 2006-08-01 2009-02-01 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy

Country Status (12)

Country Link
EP (1) EP2046335A2 (en)
JP (1) JP2009545619A (en)
KR (1) KR20090047501A (en)
CN (1) CN101657199A (en)
BR (1) BRPI0715504A2 (en)
CA (1) CA2659477A1 (en)
IL (1) IL196824A0 (en)
MX (1) MX2009001116A (en)
NO (1) NO20090279L (en)
RU (1) RU2009107123A (en)
WO (1) WO2008017000A2 (en)
ZA (1) ZA200900728B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271908A1 (en) * 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions

Also Published As

Publication number Publication date
NO20090279L (en) 2009-02-26
BRPI0715504A2 (en) 2014-05-06
WO2008017000A2 (en) 2008-02-07
WO2008017000A8 (en) 2009-04-30
RU2009107123A (en) 2010-09-10
CA2659477A1 (en) 2008-02-07
EP2046335A2 (en) 2009-04-15
CN101657199A (en) 2010-02-24
MX2009001116A (en) 2009-02-10
WO2008017000A3 (en) 2008-03-20
ZA200900728B (en) 2010-03-31
KR20090047501A (en) 2009-05-12
JP2009545619A (en) 2009-12-24

Similar Documents

Publication Publication Date Title
IL196571A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
IL184735A0 (en) Pharmaceutical formulations and methods of use
EP2056871A4 (en) Protein matrix vaccines and methods of making and administering such vaccines
EP2099449A4 (en) Pharmaceutical composition for the treatment and prevention of diseases involving impotence
IL196113A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
IL216599A (en) 1,4-disubstituted phthalazine derivatives, pharmaceutical compositions comprising them and use thereof in the treatment of cancer
EP1966246A4 (en) Methods and compositions for needleless delivery of antibodies
EP1985302A4 (en) Medicament for treatment of tumor and the use thereof
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
EP2379079A4 (en) Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
EP2497467A4 (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL194880A (en) Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them
IL196606A (en) Use of escin for the manufacture of pharmaceutical preparations and pharmaceutical compositions comprising escin for treating diseases
IL195155A (en) Delayed-release dosage form comprising glucocorticoid and uses thereof in the treatment of rheumatic disease
PL1848419T3 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
IL178636A0 (en) Compositions and methods for therapy of chemotherapy-induced neuropathy
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2005964A4 (en) The medicament for treating hyperphospheremia and preparation thereof
PT2484661T (en) 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
ZA200900899B (en) Protein matrix vaccines and methods of making and administering such vaccines
IL178635A0 (en) Compositions and methods for therapy of chemotherapy-induced neuropathy